NFKB1 and obesity disorder: Disruption of NF-κB signaling in astrocytes has been shown to ameliorate HFD-induced hypothalamic inflammation, reduce weight gain, and improve glucose tolerance, highlighting the importance of astrocytic regulation in hypothalamic responses to obesity (Figure 2; Douglass et al., 2017).